2009
DOI: 10.1002/cmdc.200900282
|View full text |Cite
|
Sign up to set email alerts
|

Combined Pharmacophore Modeling, Docking, and 3D QSAR Studies of ABCB1 and ABCC1 Transporter Inhibitors

Abstract: Quinazolinones, indolo- and pyrrolopyrimidines with inhibitory effects toward ABCB1 (P-gp) and ABCC1 (MRP1) transporters were studied by pharmacophore modeling, docking, and 3D QSAR to describe the binding preferences of the proteins. The pharmacophore overlays between dual and/or highly selective inhibitors point to binding sites of different topology and physiochemical properties for MRP1 and P-gp. Docking of selective inhibitors into the P-gp binding cavity by the use of a structural model based on the rece… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
70
0
1

Year Published

2012
2012
2022
2022

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 91 publications
(74 citation statements)
references
References 23 publications
3
70
0
1
Order By: Relevance
“…In addition, from the point of view of early absorption, distribution, metabolism, and excretion (ADME) prediction of therapeutic agents, various computational prediction models have been reported for ligand interactions with P-gp. 2,[4][5][6][7][8][9][10] In general, a P-gp substrate seems to be lipophilic or amphiphilic, having a large size or molecular volume, electronegative groups and hydrogen bonding groups. 11) Although X-ray structures of the complex of mouse P-gp with enantiomeric cyclic peptide inhibitors have been reported previously by Aller et al in 2009, 12) the mechanism of P-gp substrate/inhibitor recognition is complicated and still poorly understood.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…In addition, from the point of view of early absorption, distribution, metabolism, and excretion (ADME) prediction of therapeutic agents, various computational prediction models have been reported for ligand interactions with P-gp. 2,[4][5][6][7][8][9][10] In general, a P-gp substrate seems to be lipophilic or amphiphilic, having a large size or molecular volume, electronegative groups and hydrogen bonding groups. 11) Although X-ray structures of the complex of mouse P-gp with enantiomeric cyclic peptide inhibitors have been reported previously by Aller et al in 2009, 12) the mechanism of P-gp substrate/inhibitor recognition is complicated and still poorly understood.…”
Section: Introductionmentioning
confidence: 99%
“…9) We constructed a CoMFA model for ATPase activity produced by DBH derivatives. The model showed sterically and electronically favorable/unfavorable regions for activity.…”
mentioning
confidence: 99%
“…Dostupnost ovih struktura i modela doprinelo je racionalizaciji strukturne osnove različitih eksperimentalnih zapažanja. Više autora primenilo je molekulski doking u predviđanju strukture kompleksa Pgp-a i jedinjenja koja se za transporter vezuju [82][83][84][85][86][87]. Dobra ilustracija ovog pristupa jeste kombinovana studija mutageneze i molekulskog dokinga koju su predstavili Chufan i saradnici [88].…”
Section: Modeli Zasnovani Na Strukturi Pgp-aunclassified
“…Normal range of log BB for brain/blood varies from -3.0 to 1.2 which was favorable for all the compounds except dibenzoyalmethane (-0.388). IC 50 represents the concentration of a drug that is required for 50 % inhibition in vitro (Pajeva et al 2009). LogHERG values for 95 % drugs are concern if it is less than -5.…”
Section: \25mentioning
confidence: 99%